Aragon attracts another pharmaceutical company to install its first factory in Spain
The 25-million-euro investment will create 150 highly qualified jobs
Besins Healthcare, world leadeing company in novel therapies for gynecology, fertility, obstetrics, endocrinology and andrology, has chosen the town of Muel (Zaragoza) to install its first factory in Spain. The pharmaceutical multinational acquired a 9,800-square-meter warehouse in the industrial area El Pitarco to carry out this investment, which will reach 25 million euros and create 150 stable highly qualified jobs.
The plant is expected to start manufacturing in the second half of 2022. Construction works are already underway, soon part of the equipment will be installed so that it can be tested starting this summer. According to company sources, there could be additional future investments, “given that we are talking about a stable process of decades.” Besins has assured that, as a company in a constant research process, they contemplate the production of new creation products at the Muel plant destined for the whole world.
This new business project will be declared of Regional Interest by the Government of Aragon, which will make it possible to shorten administrative process times. In addition to this declaration, the Department of Economy, Planning and Employment is already processing, together with the company, its application file for Regional Economic Incentives. The President of Aragon, Javier Lambán, declared that this investment is particularly welcome as it is implanted in a rural area, contributing to its revitalization.
Why did Besins choose Aragon?
Besins Healthcare has chosen Aragon to install its first plant in Spain due to factors such as its geographical location and communication routes. In addition, the proximity of Muel to the University of Zaragoza facilitates the hiring or attraction of qualified personnel. Another decisive cause that has led the managers of the company to settle in Muel is the immediate availability of a spacious and empty warehouse that allows, in a short time, the integration of all the necessary facilities for the production of medicines.
Besides, according to the president of the French company, Antoine Besins, choosing Aragon has responded to objective industrial parameters. Although, among all the candidate countries -mandatorily belonging to the European Union for the application of mandatory pharmaceutical standards-, the “excellent” reception of the authorities and the facilities for the establishment of companies in the sector has entailed a keypoint to make this decision.
The Department of Economy, Planning and Employment, through Aragón Exterior (AREX), began working in 2019 on attracting the investment project of this company. Up to 14 Autonomous Communities presented location proposals in their territory. Germany, the Netherlands, Belgium or Ireland have competed with Spain, and within Spain, Aragón was the most competitive region for its dynamism and adaptation to the needs of the company.
A leading company
Besins Healthcare is a family business specialized in the development and commercialization of hormonal therapies for the treatment of gynecology and obstetrics, fertility, endocrinology and andrology. It currently produces and markets more than thirty different products that are prescribed in one hundred countries around the world.
One of the mainstays of the company is constant research. Thanks to it, it has been possible to discover innovative technologies that have an impact on improving the health of women and men throughout their lives. Besins Healthcare products include natural progesterone for pregnant women, transdermal gel for testosterone deficiency syndrome, or estradiol replacement therapies during menopause.